MedPath

Study on the mechanism of castration and metabolic syndrome in prostate cancer treated by ''Hua-Tan Tong-Luo'' approach

Phase 1
Recruiting
Conditions
PROSTATE CANCER
Registration Number
ITMCTR2000003718
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

1. Aged 18-75 years, male;
2. meet the western medicine diagnosis standard of prostate cancer;
3. meet the TCM syndrome diagnosis standard of 'deficiency of kidney Yang';
4. agree to participate in the experiment and sign the informed consent.

Exclusion Criteria

(1) complicated with cardiovascular, liver, kidney, hematopoietic system and other serious primary diseases;
(2) participate in other relevant clinical trials during the treatment period.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood lipid level;PSA;CRTC2;Evaluation of tumor progression;
Secondary Outcome Measures
NameTimeMethod
TCM syndrome score;
© Copyright 2025. All Rights Reserved by MedPath